NCT01125969

Brief Summary

In recent years, social networks have garnered attention in both academic journals and the lay press because of strong associations demonstrated in retrospective studies between social networks and incidence of major health problems such as obesity and smoking. Financial incentives have also been demonstrated to improve health behaviors in obesity, smoking, and medication adherence. We propose to conduct a randomized controlled trial among a predominantly African American population with persistently poor diabetes mellitus (DM) control to examine whether two novel interventions, lottery based financial incentives and telephone based one-on-one peer mentoring (the 'buddy system'), can significantly ameliorate disparities in poor DM control. The intervention is based on epidemiologic evidence, randomized controlled trials, and pilot studies demonstrating: 1) Lottery based financial incentives are a powerful motivator of behavior change; 2) One-on-one peer mentoring is a flexible, cost-efficient means of increasing DM specific social support and may be particularly salient in minority communities; and 3) Matching patients with poorly controlled DM with a similar individual from their community who has gained control of their DM draws on existing community assets in creating an inherently culturally competent intervention. DM patients with poor DM control will be randomized to 1 of 4 arms: usual care; telephone based one-on-one peer mentoring; lottery based financial incentives; and peer mentoring plus financial incentives. The Specific Aims are to test: 1) The effectiveness of telephone based one-on-one peer mentoring in improving glycemic control relative to usual care; 2) The effectiveness of lottery based financial incentives in improving glycemic control relative to usual care; 3) The effectiveness of combining peer mentoring and financial incentives relative to control; and 4) The relative cost effectiveness of all four approaches. In exploratory analyses, we will examine whether African American patients enrolled in intervention arms have greater improvement in glycemic control than white patients, whether intervention group patients experience greater improvements in blood pressure (BP) and lipid control, and whether peer mentors experience improvements in their own health. We will pair mentors with mentees based on race, gender, age, and disease severity. The active intervention will be run for a 6-month time period, with participants followed for an additional 6 months to determine if effects persist post intervention. The proposed interventions address multiple barriers to effective disease management common among patients with DM. If effective, these interventions could provide important models for improving glycemic control in general and, in particular, for addressing racial disparities in DM outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable diabetes-mellitus

Timeline
Completed

Started Mar 2011

Longer than P75 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2010

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 19, 2010

Completed
10 months until next milestone

Study Start

First participant enrolled

March 1, 2011

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

August 7, 2018

Status Verified

August 1, 2018

Enrollment Period

4.8 years

First QC Date

April 13, 2010

Last Update Submit

August 3, 2018

Conditions

Keywords

diabetesglucosepeer mentorincentivesbehavioral economicscost-effectiveness

Outcome Measures

Primary Outcomes (1)

  • Hemoglobin A1c

    HbA1c is a measure of the percent of glycosylated hemoglobin in the blood stream. It is an excellent biomarker reflecting glucose control for the preceding 2-3 months and thus provides a reliable and unbiased marker of patient adherence. The primary outcome will be a change in HbA1c from baseline to the 6-month follow-up visit.

    Baseline, 6 months

Secondary Outcomes (1)

  • Cost-effectiveness of change in Hemoglobin A1c

    6 months

Study Arms (4)

Control

ACTIVE COMPARATOR
Behavioral: Education

Incentive

EXPERIMENTAL
Behavioral: IncentivesBehavioral: Education

Peer Mentoring

EXPERIMENTAL
Behavioral: EducationBehavioral: Peer mentoring

Incentives and Peer Mentoring

EXPERIMENTAL
Behavioral: IncentivesBehavioral: EducationBehavioral: Peer mentoring

Interventions

IncentivesBEHAVIORAL

Incentives will be offered for checking blood glucose each morning and for control of blood glucose (between 80-140 mg/dL).

IncentiveIncentives and Peer Mentoring
EducationBEHAVIORAL

Standard brochure about improving blood sugar control plus warnings about dangers of persistently high sugars and hypoglycemia

ControlIncentiveIncentives and Peer MentoringPeer Mentoring
Peer mentoringBEHAVIORAL

Participant is assigned a peer mentor who is matched on gender, race and age and who achieved good glucose control after previously having poor glucose control.

Incentives and Peer MentoringPeer Mentoring

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with diabetes mellitus
  • to 70 years old
  • persistently poor glucose control, defined as having the last two HbA1c values \> 8%, with at least one measure within 3 months of enrollment
  • receiving treatment for diabetes mellitus at one of five University of Pennsylvania outpatient clinics

You may not qualify if:

  • does not speak English
  • unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Interventions

FertilityEducational Status

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Reproductive Physiological PhenomenaReproductive and Urinary Physiological PhenomenaSocioeconomic FactorsPopulation Characteristics

Study Officials

  • Judith A. Long, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2010

First Posted

May 19, 2010

Study Start

March 1, 2011

Primary Completion

December 1, 2015

Study Completion

December 1, 2016

Last Updated

August 7, 2018

Record last verified: 2018-08

Locations